1 Background Anticoagulant and antiplatelet therapy is increasingly common in populations undergoing cutaneous facial reconstruction after Mohs micrographic surgery or excision of cutaneous malignancies. Perioperative continuation of these agents may increase the risk of postoperative hemorrhagic complications, particularly in the well-vascularized head and neck region.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Isabelle
Contact Isabelle, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack